Mylan, Teva To Resolve Pending Patent Litigation Related To Nuvigil

RELATED NEWS

Trade MYL now with

4/30/2012 8:15 AM ET

Mylan Inc. (MYL: Quote) said it has entered into a settlement agreement with Teva that will resolve pending patent litigation related to Nuvigil (Armodafinil Tablets, 50 mg, 150 mg, and 250 mg).

The settlement allows Mylan to begin selling generic versions of 50 mg, 150 mg, and 250 mg Nuvigil under license beginning in June 2016, or earlier under certain circumstances. Pursuant to the agreement, pending litigation will be dismissed.

Mylan stated that other details of the settlement are confidential, and the agreement itself is subject to review by the U.S. Department of Justice and the Federal Trade Commission.

Click here to receive FREE breaking news email alerts for Mylan Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

<<Previous 164 Articles Next>>

Editors Pick

Fed Concerns Contribute To Lackluster Session On Wall Street - U.S. Commentary

There was a mixed performance on Wall Street on Friday. Shares suffered an early decline, as investors continued to express worries about the Federal Reserve. A recovery through the rest of the day allowed the Dow to edge into positive territory by the close. The Nasdaq and S&P 500 posted fractional losses.

Stocks Come Under Pressure Amid Worries About The Fed - U.S. Commentary

Stocks have shown a notable move to the downside in early trading on Friday amid lingering concerns about the outlook for the Federal Reserve's asset purchase program. The major averages have slid firmly into negative territory, adding to the modest losses posted in the previous session. The major averages are currently posting notable losses, near their lows for the young session.

U.S. Durable Goods Orders Rise 3.3% In April, More Than Expected

After reporting a sharp drop in new orders for manufactured durable goods in the previous month, the Commerce Department released a report on Friday showing that durable goods orders rebounded by more than anticipated in the month of April. The report said durable goods orders surged up by 3.3 percent in April after tumbling by a revised 5.9 percent in March.

Mylan, Teva To Resolve Pending Patent Litigation Related To Nuvigil

FDA Panel Backs Merck Insomnia Drug Suvorexant, But At Lower Doses

WSJ: Fidelity National, Thomas H Lee In Talks To Buy Lender Processing Services

Covidien Nellcor Pulse Oximetry Portfolio Gets 510(k) Clearance For Motion Claim

Plains Exploration Declars Special Dividend - Quick Facts

Goodman Networks, Multiband To Merge In $116 Mln Cash Deal - Quick Facts

Genesys To Buy SoundBite Communications For $5.00 Per Share

GE Capital To Pay $6.5 Bln In Dividends To GE In 2013, Plans Special Dividend

Dolphin Capital Announces Sale Of Venus Rock Golf Resort Interest

NetApp Profit Tops Estimates; Boosts Buyback; Initiates Dividend

G4S Plc Names Ashley Almanza CEO; Eddie Aston Named New COO

Invensys To Return About GBP 625 Mln Cash To Shareholders - Quick Facts

WSJ: Fidelity National, Thomas H Lee In Talks To Buy Lender Processing Services

Hercules Offshore To Sell Majority Of Inland Fleet For Approx. $45 Mln

EveryWare Global, ROI Acquisition Complete Business Combination

MRPL Posts Q4 Loss On Higher Costs

Covidien Nellcor Pulse Oximetry Portfolio Gets 510(k) Clearance For Motion Claim

GE Capital To Pay $6.5 Bln In Dividends To GE In 2013, Plans Special Dividend

Ensco Shareholders Elect 2 Directors, Pass $2 Bln Share Repurchase Authorization

AIG To Invest $92.5 Mln In Rights Offering By China's PICC

G4S Plc Names Ashley Almanza CEO; Eddie Aston Named New COO